Clinical Trial Update: A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pemetrexed/cisplatin as pre-operative treatment for early-stage nonsquamous non-small cell lung cancer. Completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pemetrexed/cisplatin

Snippet

Sponsor: Eli Lilly and Company | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-05-21